May 25, 2024, 14:20
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on X and added:
“Just in ASCO Daily News where Nazli Dizman, Emre Yekedüz, and I briefly discuss immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC, under the mentorship of Toni Choueiri!”
Quoting ASCO‘s post:
“For ASCO Daily News, Toni Choueiri, Nazli Dizman, Marc Machaalani, and Emre Yekedüz examine recent/ongoing research efforts exploring IO rechallenge after prior ICI exposure to understand its potential in mRCC.”
Source: Marc Machaalani/X and ASCO/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 15:44
Oct 23, 2024, 15:44
Oct 23, 2024, 15:42
Oct 23, 2024, 15:15
Oct 23, 2024, 15:07
Oct 23, 2024, 15:04
Oct 23, 2024, 15:00